Margaret Ottaviano

16PUBLICATIONS
53CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 16, 2025
When rarity meets thoracic cancers: a narrative review from ITMIG 2024.

Margaret Ottaviano, Paolo Antonio Ascierto, Erica Pietroluongo

|Jul 09, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.

Domenico Mallardo, Mario Fordellone, Michael Bailey

|Nov 27, 2024
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.

Domenico Mallardo, Mario Fordellone, Margaret Ottaviano

|Sep 08, 2023
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.

Domenico Mallardo, Mario Fordellone, Andrew White

|Mar 29, 2023
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype.

Aldo Caltavituro, Roberto Buonaiuto, Erica Pietroluongo

|Feb 24, 2023
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.

Domenico Mallardo, Ester Simeone, Lucia Festino

Pageof 3

Frequent Collaborators

5 joint publications

Emilio Francesco Giunta

5 joint publications

Marianna Tortora

5 joint publications

Bruno Daniele

4 joint publications

Domenico Mallardo